课题基金 / 基金详情

Insight into pathological self assembly using alpha-helical mimetics

Insight into pathological self assembly using alpha-helical mimetics
使用 α 螺旋模拟物洞察病理自组装
批准号:
8635365
负责人:
ANDREW D. MIRANKER
金额:
$31.6万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-04-01 至 2015-06-30

项目摘要

项目成果

ANDREW D. MIRANKER的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The primary goal of this proposal is the design of small molecule compounds which target newly identified protein structures with direct relevance to insulin secreting 2-cell viability in type II diabetes. Islet amyloid polypeptide (IAPP) is a 37-residue peptide hormone, which is co-secreted with insulin by the 2-cells of the endocrine pancreas. IAPP belongs to a class of aggregation prone proteins, which includes A2 from Alzheimer's, in which a wild-type protein precursor irreversibly forms/folds into 2-sheet rich fibrillar amyloid plaques. The origin of 2-cell death in type II diabetes is poorly understood. Like most amyloid diseases, it is the presence, rather than the extent, of amyloid deposition that is correlated with pathology. Instead, it is the intermediates of the assembly reaction that have been implicated in cell death. Importantly, this cytotoxicity is mediated by the formation of membrane bound protein structures. In the case of IAPP, this is highly intriguing since, despite the 2-sheet nature of mature amyloid, membrane bound states are 1-helical. The overall hypothesis pursued by this proposal is that small-molecule, structure based targeting of pre-amyloidogenic states will enable elucidation of the mechanism of IAPP induced cytotoxicity. These efforts will provide novel descriptions of IAPP oligomerization at a molecular level, and provide a rational design path for the creation of lead compounds that ameliorate 2-cell death. Our concurrently pursued aims include synergistic efforts in synthetic chemistry, cell and structural biology. Importantly, we will target the 1-helical intermediates of IAPP by synthesizing small molecules designed to mimic the surface presentation of one edge of an 1-helix. Cellular methods will be developed to assess toxicity and localization of IAPP. Diffraction, NMR and computational methods will be employed to elucidate the alternative oligomeric states at atomic resolution and to provide structure based guidance for small molecule synthesis.
期刊论文(9)
专著(0)
科研奖励(0)
会议论文
Small molecule screening in context: lipid-catalyzed amyloid formation.
小分子筛选背景:脂质催化淀粉样蛋白形成。
DOI: 10.1002/pro.2518
发表时间: 2014
期刊: Protein science : a publication of the Protein Society
影响因子: --
作者: [Hebda,JamesA, Magzoub,Mazin, Miranker,AndrewD]
通讯作者: Miranker,AndrewD
Structure-Based Small Molecule Modulation of a Pre-Amyloid State: Pharmacological Enhancement of IAPP Membrane-Binding and Toxicity.
基于结构的前淀粉样蛋白状态的小分子调节:IAPP 膜结合和毒性的药理学增强。
DOI: 10.1021/acs.biochem.5b00052
发表时间: 2015
期刊: Biochemistry
影响因子: 2.9
作者: [Nath,Abhinav, Schlamadinger,DianaE, Rhoades,Elizabeth, Miranker,AndrewD]
通讯作者: Miranker,AndrewD
DOI: 10.1038/ncomms11412
发表时间: 2016-04-25
期刊: Nature communications
影响因子: 16.6
作者: [Kumar S, Birol M, Schlamadinger DE, Wojcik SP, Rhoades E, Miranker AD]
通讯作者: Miranker AD
DOI: 10.1039/c3cc41452c
发表时间: 2013-05-25
期刊: Chemical communications (Cambridge, England)
影响因子: --
作者: [Kumar S, Miranker AD]
通讯作者: Miranker AD
6
    AMYLOIDOGENIC INDUCTION OF CELLULAR SENESCENCE IN ALZHEIMER'S DISEASE
    • 批准号:
      10672372
    • 项目类别:
    • 资助金额:
      $41.49万
    • 财政年份:
      2020
    • 负责人:
      ANDREW D. MIRANKER
    • 依托单位:
    AMYLOIDOGENIC INDUCTION OF CELLULAR SENESCENCE IN ALZHEIMER'S DISEASE
    • 批准号:
      10456063
    • 项目类别:
    • 资助金额:
      $41.15万
    • 财政年份:
      2020
    • 负责人:
      ANDREW D. MIRANKER
    • 依托单位:
    An orderly approach to toxic mechanism by disorderly peptides
    • 批准号:
      8365310
    • 项目类别:
    • 资助金额:
      $34.97万
    • 财政年份:
      2012
    • 负责人:
      ANDREW D. MIRANKER
    • 依托单位:
    An orderly approach to toxic mechanism by disorderly peptides
    • 批准号:
      8546428
    • 项目类别:
    • 资助金额:
      $33.61万
    • 财政年份:
      2012
    • 负责人:
      ANDREW D. MIRANKER
    • 依托单位: